Phase 1 and 2 Randomized Clinical Studies Determine Lack of Efficacy for Anti-IL-17C Antibody MOR106 in Moderate-Severe Atopic Dermatitis
1期和2期随机临床研究确定抗IL-17C抗体MOR106对中重度特应性皮炎无效
期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm11237244
Thaçi, Diamant; Singh, Dave; Lee, Mark; Timmis, Helen; Jacobs, Dominique; Passier, Paul; Rohrer, Susanne; Beetens, Johan; Phung, De; Sondag, Eric; Babic, Goran; Würth, Guido; Kloepfer, Pia; Härtle, Stefan; Hüttner, Silke
